AMT Secures Option to License Sanfilippo B Gene Therapy from Institut Pasteur-Led Consortium

Firm may acquire full commercial rights to French consortium-developed product at end of Phase I/II trial.

Pall to Sell Blood Collection, Filtration, Processing Assets to Haemonetics for $550M

Deal includes equipment for transfusion medicine and production plants.

GE Grows Massachusetts Plant

GE Healthcare Life Sciences announced today they are investing $7 million to expand their manufacturing facility in Westborough, MA.

Lonza Launches Cells on Demand Services for Cell Culture and Transfection

Lonza launched Cells on Demand™ Cell Culture and Transfection Services as a new offering for assay-ready cells for cell-based screening. Lonza says the new services cover bulk cell production, transfection services, cell-isolation services, and...

Quanterix to Automate SiMoA™ Platform in Deal with Stratec

Companies expect to launch a product for the life sci market by 2013 and for the IVD segment by 2014.
CRISPR-Cas9 protein

Novel CRISPR-Cas9 Variants Generated by Diverse Means

CRISPR-Cas9 can perform its usual tasks more ably, or assume new ones, if it is subjected to protein engineering. The available protein engineering approaches include rational design, directed evolution, and domain fusion.
vaccine manufacturing

A Shot in the Arm for Vaccine Manufacturing

Vaccine science has come a long way since the 18th century, when Edward Jenner used pus from a milkmaid’s sore to stop a child from catching smallpox.1 Since then, various vaccines have been developed,...

U.S. Drug Manufacturing Decline Reflects Wage Gap and Regulatory Scrutiny

Last week’s Congressional hearing on the fifth authorization of the Prescription Drug User Fee Act (PDUFA V) didn’t get much news coverage beyond outlets covering the industry. Some sobering statistics brought out by FDA...
Figure 1

Transient Gene Expression Seeds Plant-Based Bioproduction Systems

Recent advances in plant biotechnology have allowed the use of plants and plant cell cultures for the production of pharmaceutical proteins, known as molecular farming. We are now able to exploit the ability of...

Pevion to Use Cevec’s Protein-Expression Technology for Infectious Disease Vaccine

CAP-T system will be used to manufacture protein antigen being evaluated in preclinical studies.

Recently Featured

Stay Connected

555,437FansLike
48,408FollowersFollow
Scroll Up